SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-17-010642
Filing Date
2017-10-17
Accepted
2017-10-17 16:05:07
Documents
1
Group Members
ENRICO CAVAZZAESSETIFIN S.P.A.FRANCESCA CAVAZZAMARTINA CAVAZZA PRETAPAOLO CAVAZZASILVIA CAVAZZATAUFIN INTERNATIONAL S.A.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 19 TO FORM SC 13D sc13d1017a19sinaf_regen.htm SC 13D/A 173539
  Complete submission text file 0001213900-17-010642.txt   175360
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 171140785
SIC: 2834 Pharmaceutical Preparations

Mailing Address 26 BOULEVARD ROYAL LUXEMBOURG N4 L-2449
Business Address 26 BOULEVARD ROYAL LUXEMBOURG N4 L-2449 00352-26478360
Sinaf S.A. (Filed by) CIK: 0001495790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A